- Lab Tests
- Health Corner
LORFAST MT is a combination of Levocetirizine and Montelukast which belongs to the group of medicines called H1 receptor antagonists and Leukotriene receptor antagonists respectively. LORFAST MT is indicated for the treatment and prevention of allergic rhinitis, chronic idiopathic urticaria (allergic skin reaction with red raised itchy bumps on skin) and bronchial asthma in adults and in adolescents (aged 15 years or above).
Allergic rhinitis (also known as hay fever) is a heterogeneous disorder characterized by inflammation of the inner lining of nose accompanied by nasal decongestion, repeated sneezing, wheezing, or a red, watery and itchy eyes.
It is usually caused by allergens such as pollens, dusts, mould or flakes of skin from certain animals and can occur seasonally or year-round. Bronchial asthma is a long-term medical condition in which the path of the airways becomes inflamed, narrow and swollen. Symptoms include coughing, wheezing and chest tightness.
LORFAST MT is contraindicated for use in patients having severe kidney impairment. Consult your doctor before use. Avoid consumption of alcohol while taking LORFAST MT as it could make you feel drowsier.
LORFAST MT may cause certain unpleasant neuropsychiatric events (such as anxiety, depression, nightmares, hallucinations or even suicidal thoughts) in some individuals. Contact your doctor immediately if you or anyone else experience such events during treatment with LORFAST MT.
The most common side effects of taking LORFAST MT are upper respiratory tract infection, fever, cough, inflammation of the pharynx, dryness of mouth, headache and sleepiness. Consult your doctor if any of the side effects worsen.
LORFAST MT provides relief from the symptoms of allergic rhinitis, asthma and urticaria where levocetirizine acts by blocking the actions of histamines (a substance that cause allergic reaction), at the H1 receptors present on the surface of cells and montelukast acts by blocking the action of leukotrienes D4 (an inflammatory molecule causing narrowing and swelling of the airways) in the lungs, thus causing relaxation of smooth muscle, reduction in swelling and/or inflammation of the airways and a marked decrease in the onset of allergic reactions.
Take LORFAST MT as advised by your physician. Swallow LORFAST MT with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of LORFAST MT for you depending upon your age, body weight and disease condition.
Stop giving LORFAST MT to your child and contact doctor immediately if your child experiences any of the following side effects:
Drink lots of fluids such as water or fruit juices to keep yourself hydrated. Avoid taking any medicine on your own for treating diarrhea. Consult your doctor if the symptom did not improve.
Try to rest and relax. Get enough sleep. Avoid driving or operating any tools or machines while you are feeling dizzy. Do not consume too much of alcohol, as it can aggravate your dizziness. Consult your doctor if the symptom did not improve.
Rest and relax. Drink plenty of fluids such as water or electrolytes. Apply a pain-relieving balm on the forehead if required. Do not consume too much of alcohol. Consult your doctor if the symptom did not improve.
Try to take LORFAST MT with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if the symptom did not improve.
Rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. Do not self-treat on your own and consult your doctor if the symptom did not improve.
LORFAST MT should be used with caution during pregnancy only if considered clearly necessary. Consult your doctor before taking LORFAST MT.
LORFAST MT should be used with caution in breast-feeding. Consult your doctor before taking LORFAST MT.
Do not drive or operate any machines if you experience sleepiness/drowsiness, fatigue or physical weakness. Consult your doctor before taking LORFAST MT.
Avoid consumption of alcohol while taking LORFAST MT as it could cause reduction in alertness and impairment of performance. Consult your doctor before taking LORFAST MT.
LORFAST MT is not recommended for use in patients with severe kidney impairment. It should be taken with extreme caution in patients with kidney disease. Consult your doctor before taking LORFAST MT.
LORFAST MT should be taken with caution in patients with liver disease. Consult your doctor before taking LORFAST MT.
Do not take LORFAST MT if you are allergic to Montelukast or Levocetirizine. Consult your doctor before taking LORFAST MT.
LORFAST MT is not recommended for use in patients with asthma attacks. Consult your doctor before taking LORFAST MT.
LORFAST MT is strictly not recommended for use in infants and children (aged below 15 years). Consult your child’s doctor for advice.
LORFAST MT should be used with caution in elderly patients (aged 65 years or above). Proper dose titrations and careful monitoring of kidney functions are required in such patients. Consult your doctor before taking LORFAST MT.
LORFAST MT is not recommended for use if you:
Before taking LORFAST MT, inform your physician if you:
A. Drug-Drug interactions:
Before taking LORFAST MT, inform your doctor, if you are taking any of the following medicines:
If you or anyone else take too much of LORFAST MT, contact your doctor immediately or go to a hospital straight away. Overdosage symptoms of LORFAST MT might include stomach pain, thirst, sleepiness, headache, vomiting, hyperactivity, agitation, excitation and restlessness.
|Pharmacological Category||:||H1 receptor antagonist, Leukotriene receptor antagonist|
|Therapeutic Indication||:||Allergic rhinitis, Bronchial asthma, Chronic idiopathic urticaria|
|Dosage Forms||:||Tablet, Capsule, Softgel capsule, Dispersible tablet, Syrup, Suspension|
Q: How long does it take for LORFAST MT to provide relief from symptoms?
A: Following oral administration with LORFAST MT, it is believed to provide relief from the symptoms of allergy and asthma within 30 minutes to an hour. Please note that the onset of action varies from product to product and consult your doctor if you have any queries.
Q: Can LORFAST MT be used to treat acute asthma attacks?
A: No, LORFAST MT is used only to prevent asthma attacks. LORFAST MT should not be used on an asthma attack that has been started already. Contact your doctor or go to the nearby hospital to avoid exacerbation of the attack.
Q: Can LORFAST MT be used in infants?
A: No, LORFAST MT is only meant to be used in adults and in adolescents (aged 15 years or above). LORFAST MT is strictly not recommended for use in children aged between 6 months to 11 years of age without consulting your doctor.
Q: Can LORFAST MT make you feel sleepy?
A: Yes, LORFAST MT may make you feel sleepy or drowsy. Try to rest and relax. Get enough sleep. Avoid driving or operating any tools or machines while you are feeling sleepy. Avoid alcohol intake, as it could aggravate your existing condition. Consult your doctor if the symptom did not improve.
Q: Is LORFAST MT safe to use in patients with kidney problems?
A: LORFAST MT is not recommended for use in patients with severe kidney impairment. It should be taken with extreme caution in patients with kidney disease. Consult your doctor before taking LORFAST MT.
1. KD. Tripathi. Histamines and Antihistamines & Drugs for cough and bronchial asthma. Essentials of medical pharmacology. Seventh edition. 2013. Page – 166-168 & 228-229.
2. Peter J. Barnes. Pulmonary pharmacology. Randal A. Skidgel, Allen P. Kaplan and Ervin G. Erdos. Histamine, Bradykinin, and their antagonists. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 918-923 & 1052-1054.
3. Gerald G. Briggs and Roger K. Freeman. L & M. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 2219-2220 & 2629-2632.
4. Sheila Jacobs. Montelukast Plus Levocetirizine vs Monotherapy in Asthma, Allergic Rhinitis. Pulmonology adviser. [Revised in October 2018]. [Accessed on 13th October 2021] https://www.pulmonologyadvisor.com/home/meetings/chest-2018/montelukast-plus-levocetirizine-vs-monotherapy-in-asthma-allergic-rhinitis/#:~:text=Perennial%20Allergic%20Rhinitis-,Montelukast%20plus%20levocetirizine%20was%20well%20tolerated%2C%20with%20a%20safety%20profile,perennial%20allergic%20rhinitis%20and%20asthma.
5. S M Adsule, D Misra. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. [Revised in June 2010] [Accessed on 13th October 2021] https://pubmed.ncbi.nlm.nih.gov/21121394/
6. Mi-Kyeong Kim, Sook Young Lee, Hae-Sim Park, Ho Joo Yoon, Sang-Ha Kim, Young Joo Cho, Kwang-Ha Yoo, Soo-Keol Lee, Hee-Kyoo Kim, Jung-Won Park, Heung-Woo Park, Jin-Hong Chung, Byoung Whui Choi, Byung-Jae Lee, Yoon-Seok Chang, Eun-Jung Jo, Sang-Yeub Lee, You Sook Cho, Young-Koo Jee, Jong-Myung Lee, Jina Jung, Choon-Sik Park. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. [Revised in July 2018] [Accessed on 13th October 2021] https://pubmed.ncbi.nlm.nih.gov/29945738/
7. E Nettis, G F Calogiuri, E Di Leo, F Cardinale, L Macchia, A Ferrannini, and A Vacca. Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria. NCBI; PMC US National Library of Medicine, National Institute of Health. 2009. [Accessed on 13th October 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048603/
8. TusharKanti Sarkar. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial. ResearchGate. Indian Journal of Dermatology, Venereology and Leprology. June 2017. [Accessed on 13th October 2021] https://www.researchgate.net/publication/317945813_Effectiveness_and_safety_of_levocetirizine_10_mg_versus_a_combination_of_levocetirizine_5_mg_and_montelukast_10_mg_in_chronic_urticaria_resistant_to_levocetirizine_5_mg_A_double-blind_randomized_contr
9. Paulina Korczynska-Krawczyk, Iabela Kuprys-Lipiñska, Maciej Kupczyk, Malgorzata Wagrowska-Danilewicz, Janusz Szemraj, Wojciech Bienias, Joanna Narbutt, Janusz Smigielski, and Piotr Kuna. The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria – a pilot study. NCBI; PMC US National Library of Medicine, National Institute of Health. [Revised in February 2020]. [Accessed on 13th October 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247068/
10. Cipla Ltd. Montair LC & Montair LC Kid DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride). Ciplamed.com. [Revised in December 2020]. [Accessed on 13th October 2021] https://www.ciplamed.com/content/montair-lc-montair-lc-kid-dt-syrup
11. Cipla Ltd. Rid -AR Tablets & Rid-AR Kid DT/Syrup (Montelukast sodium + Levocetirizine dihydrochloride). Ciplamed.com. [Revised in November 2013]. [Accessed 13th October 2021] https://www.ciplamed.com/content/rid-ar-tablets-rid-ar-kid-dtsyrup
12. Torrent pharmaceuticals Ltd. Lezyncet-M. Torrentian.com. April 2020. [Accessed on 13th October 2021] https://www.torrentian.com/pisheet/Upload/PI_Sheet/2916.pdf
13. RND Laboratories. Laboratories division. Rnd Kast-L10 Tablets. [Accessed on 13th October 2021] http://www.rndlaboratories.com/laboratories_division.php
14. Viilbery Healthcare Pvt Ltd. Anti-allergic. Alocet M tablet. [Accessed on 13th October 2021] https://viilbery.com/products/anti-allergic/alocet-m-tablet.html#parentVerticalTab2
15. Glenmark Pharmaceuticals s.r.o. Tillomed Laboratories Ltd. And Glenmark Pharmaceuticals Europe Limited. Electronic Medicines Compendium (EMC). [Revised in November 2019] [Accessed on 13th October 2021] https://www.medicines.org.uk/emc/files/pil.9917.pdf
16. Accord Healthcare Limited. Electronic Medicines Compendium (EMC). [Revised in September 2020] [Accessed on 13th October 2021] https://www.medicines.org.uk/emc/files/pil.1243.pdf
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 24 Feb 2023 | 10:19 AM(IST)
Levocetirizine+Montelukast TABLET : Therapeutic Uses, Warning and Precautions, Interactions, Directions for Use, Side Effects and Storage
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.